Skip to content

TherapeuticsMD, Inc.: 10-Q filed 2020-08-07

What TherapeuticsMD, Inc. reported in its quarterly report filed 2020-08-07 (fiscal Q2 2020): 42 published measures, 114 facts as tagged in accession 0001387131-20-007144.

This filing

Form
10-Q (quarterly report)
Filed
2020-08-07
Fiscal period
fiscal Q2 2020
Accession
0001387131-20-007144 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TherapeuticsMD, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-30205,538,913USD
At 2019-12-31265,985,637USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-06-30299,627,796USD
At 2019-12-31256,784,517USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-30-94,088,883USD
At 2020-03-31-45,209,120USD
At 2019-12-319,201,120USD
At 2019-06-308,093,969USD
At 2019-03-3160,693,222USD
At 2018-12-3197,524,121USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-51,976,664USD91
2020-01-01 to 2020-06-30-108,825,466USD182
2020-01-01 to 2020-03-31-56,848,802USD91
2019-04-01 to 2019-06-30-55,236,517USD91
2019-01-01 to 2019-06-30-94,742,892USD181
2019-01-01 to 2019-03-31-39,506,375USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-95,100,299USD182
2019-01-01 to 2019-06-30-88,677,723USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-01-01 to 2020-06-3025,800USD182
2019-01-01 to 2019-06-301,092,504USD181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2020-04-01 to 2020-06-3010,701,033USD91
2020-01-01 to 2020-06-3022,951,690USD182
2019-04-01 to 2019-06-306,078,865USD91
2019-01-01 to 2019-06-3010,025,516USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-06-3048,916,184USD182
2019-01-01 to 2019-06-30111,787,118USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-806,364USD182
2019-01-01 to 2019-06-30-1,876,171USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-804,246,745USD
At 2019-12-31-695,421,279USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-06-302,145,926USD
At 2019-12-312,507,775USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-06-305,369,279USD182
2019-01-01 to 2019-06-305,224,212USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-45,038,669USD91
2020-01-01 to 2020-06-30-95,960,907USD182
2019-04-01 to 2019-06-30-41,636,873USD91
2019-01-01 to 2019-06-30-79,741,951USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-06-30148,943,917USD
At 2019-12-31208,416,180USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-04-01 to 2020-06-307,026,853USD91
2020-01-01 to 2020-06-3013,288,899USD182
2019-04-01 to 2019-06-304,028,609USD91
2019-01-01 to 2019-06-306,118,627USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-3046,483,730USD
At 2019-12-3153,004,825USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-06-3017,270,319USD
At 2019-12-3119,181,212USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-06-3018,290,784USD
At 2019-12-3124,395,958USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-04-01 to 2020-06-3051,339,217USD91
2020-01-01 to 2020-06-30111,797,061USD182
2019-04-01 to 2019-06-3046,466,878USD91
2019-01-01 to 2019-06-3087,755,780USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-06-3010,172,312USD
At 2019-12-3111,860,716USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-306,300,548USD91
2020-01-01 to 2020-06-3015,836,154USD182
2019-04-01 to 2019-06-304,830,005USD91
2019-01-01 to 2019-06-308,013,829USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2020-04-01 to 2020-06-3048,340,628USD91
2020-01-01 to 2020-06-30105,267,649USD182
2019-04-01 to 2019-06-3041,387,451USD91
2019-01-01 to 2019-06-3076,251,533USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-04-01 to 2020-06-302,742,032USD91
2020-01-01 to 2020-06-306,010,861USD182
2019-04-01 to 2019-06-304,964,368USD91
2019-01-01 to 2019-06-3011,282,250USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-06-30272,294,380shares
At 2019-12-31271,177,076shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2020-06-30113,839,234USD
At 2019-12-31160,829,713USD
At 2019-06-30182,846,301USD
At 2018-12-31161,613,077USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-06-3010,337,577USD
At 2019-12-3110,109,154USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-06-3011,414,774USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-06-303,502,399USD
At 2019-12-313,476,599USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-06-301,356,473USD
At 2019-12-31968,824USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2020-06-305,942,873USD
At 2019-12-315,258,211USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-06-3054,449,070USD
At 2019-12-3155,061,682USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-06-3035,000USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-06-306,641,587USD
At 2019-12-3111,329,793USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-51,976,664USD91
2020-01-01 to 2020-06-30-108,825,466USD182
2019-04-01 to 2019-06-30-55,236,517USD91
2019-01-01 to 2019-06-30-94,742,892USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-04-01 to 2020-06-30188,810USD91
2020-01-01 to 2020-06-30387,649USD182
2019-04-01 to 2019-06-3066,556USD91
2019-01-01 to 2019-06-30133,049USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2020-04-01 to 2020-06-3067,748USD91
2020-01-01 to 2020-06-30130,902USD182
2019-04-01 to 2019-06-3048,503USD91
2019-01-01 to 2019-06-3088,948USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-6,937,995USD91
2020-01-01 to 2020-06-30-12,864,559USD182
2019-04-01 to 2019-06-30-13,599,644USD91
2019-01-01 to 2019-06-30-15,000,941USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-01-01 to 2020-06-3012,032,014USD182
2019-01-01 to 2019-06-306,989,570USD181

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2020-01-01 to 2020-06-30670,793USD182
2019-01-01 to 2019-06-30564,092USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-6,286,974USD182
2019-01-01 to 2019-06-307,486,691USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-304,276,735USD182
2019-01-01 to 2019-06-304,226,770USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-1,910,893USD182
2019-01-01 to 2019-06-30-3,244,603USD181

Inspect the source

Entity
TherapeuticsMD, Inc. / CIK 0000025743
Captured
2026-09-19T14:45:35.881Z
SEC response SHA-256
566f636dfc852372b704143e2678a66d8d716f0795f8652994459dcc9f22859d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000025743.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))